Articles written by: NIck Bivins

Reviewing BioPharmX Corporation (BPMX)’s and IntelliPharmaCeutics International Inc. (NASDAQ:IPCI)’s results

BioPharmX Corporation (NYSEAMERICAN:BPMX) and IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) compete with each other in the Biotechnology sector. We will analyze and contrast their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioPharmX Corporation N/A 296.11 […]

Ligand Pharmaceuticals Incorporated (LGND)’s Financial Results Comparing With KemPharm Inc. (NASDAQ:KMPH)

This is therefore a comparing of the analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and KemPharm Inc. (NASDAQ:KMPH). The two are both Biotechnology companies that compete with one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Comparing of Western Asset Mortgage Capital Corporation (WMC) and MMA Capital Holdings Inc. (NASDAQ:MMAC)

Western Asset Mortgage Capital Corporation (NYSE:WMC) and MMA Capital Holdings Inc. (NASDAQ:MMAC), both competing one another are Mortgage Investment companies. We will compare their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Western Asset […]

Comparison of DSW Inc. (DSW) and Genesco Inc. (NYSE:GCO)

Both DSW Inc. (NYSE:DSW) and Genesco Inc. (NYSE:GCO) are Apparel Stores companies, competing one another. We will contrast their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DSW Inc. 3.05B 0.71 37.06M 0.57 50.04 […]

Reviewing Provident Financial Holdings Inc. (PROV)’s and Eagle Financial Bancorp Inc. (NASDAQ:EFBI)’s results

Provident Financial Holdings Inc. (NASDAQ:PROV) and Eagle Financial Bancorp Inc. (NASDAQ:EFBI) compete with each other in the Savings & Loans sector. We will analyze and compare their dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Comparing of AnaptysBio Inc. (ANAB) and Alder BioPharmaceuticals Inc. (NASDAQ:ALDR)

AnaptysBio Inc. (NASDAQ:ANAB) and Alder BioPharmaceuticals Inc. (NASDAQ:ALDR) are two firms in the Biotechnology that compete against each other. Below is a comparison of their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AnaptysBio […]

Arcturus Therapeutics Ltd. (ARCT) and Five Prime Therapeutics Inc. (NASDAQ:FPRX) Comparison side by side

Arcturus Therapeutics Ltd. (NASDAQ:ARCT) and Five Prime Therapeutics Inc. (NASDAQ:FPRX) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net […]

Dare Bioscience Inc. (DARE) and Ocular Therapeutix Inc. (NASDAQ:OCUL) Comparing side by side

As Biotechnology companies, Dare Bioscience Inc. (NASDAQ:DARE) and Ocular Therapeutix Inc. (NASDAQ:OCUL) are our subject to contrast. And more specifically their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dare Bioscience Inc. N/A 0.00 […]

Otonomy Inc. (OTIC) and Neuralstem Inc. (NASDAQ:CUR) Comparison side by side

Since Otonomy Inc. (NASDAQ:OTIC) and Neuralstem Inc. (NASDAQ:CUR) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation of both companies. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Hutchinson Capital Management Lowered Its Thor Inds Com (THO) Stake; Fuller & Thaler Asset Management Has Raised Its Tri Pointe Group (TPH) Holding

Hutchinson Capital Management Lowered Its Thor Inds Com (THO) Stake; Fuller & Thaler Asset Management Has Raised Its Tri Pointe Group (TPH) Holding

Hutchinson Capital Management decreased Thor Inds Inc Com (THO) stake by 16.46% reported in 2018Q4 SEC filing. Hutchinson Capital Management sold 10,924 shares as Thor Inds Inc Com (THO)’s stock rose 0.26%. The Hutchinson Capital Management holds 55,436 shares with $2.88 million value, down from 66,360 last quarter. Thor Inds […]